Reports for TEVA-SPIRONOLACTONE/HCTZ
Brand name
TEVA-SPIRONOLACTONE/HCTZ
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
00613231 |
Ingredients
HYDROCHLOROTHIAZIDE SPIRONOLACTONE |
Ingredient Strength
25 MG 25 MG |
ATC Code
C03EAC03EA |
ATC Descriptor
DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-SPIRONOLACTONE/HCTZ | 100 | Resolved | 2017-08-02 | 2017-11-07 | 18021 |
TEVA-SPIRONOLACTONE/HCTZ | 100 | Resolved | 2020-04-03 | 2020-06-04 | 110785 |
TEVA-SPIRONOLACTONE/HCTZ | 100 | Resolved | 2020-11-06 | 2021-02-05 | 128022 |
TEVA-SPIRONOLACTONE/HCTZ | 100 | Resolved | 2022-03-24 | 2022-04-21 | 157262 |
TEVA-SPIRONOLACTONE/HCTZ | 100 | Resolved | 2022-12-01 | 2023-02-16 | 176842 |
Showing 1 to 5 of 5
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0